Lanlan Si
Impact in
- Epidemiology top 10%
- Hepatitis B Virus Studies
-
- Traditional Chinese Medicine Analysis
Papers in
- Epidemiology 21
- Hepatitis B Virus Studies 21
- Co-authors
- Dongping Xu (16 shared papers)Zhihui Xu (9 shared papers)Rongjuan Chen (8 shared papers)Yan Liu (13 shared papers)Xiaodong Li (6 shared papers)Yan Liu (4 shared papers)Jianhong Chen (3 shared papers)Hao Liao (6 shared papers)
In The Last Decade
Lanlan Si
21 papers receiving 380 citations
Peers
Comparison fields: 5 of 30
- Epidemiology 323
- Complementary and alternative medicine 10
- Pharmacology 11
- Hepatology 6
- Genetics 16
Countries citing papers authored by Lanlan Si
This map shows the geographic impact of Lanlan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Si more than expected).
Fields of papers citing papers by Lanlan Si
This network shows the impact of papers produced by Lanlan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Si. The network helps show where Lanlan Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 56 | |
| 2 | 2010 | 44 | |
| 3 | 2016 | 44 | |
| 4 | 2012 | 32 | |
| 5 | 2018 | 29 | |
| 6 | 2017 | 25 | |
| 7 | 2017 | 21 | |
| 8 | 2021 | 21 | |
| 9 | 2019 | 20 | |
| 10 | 2017 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2023 | 14 | |
| 13 | 2010 | 13 | |
| 14 | 2021 | 9 | |
| 15 | 2020 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2024 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2023 | 3 | |
| 20 | Phenotypic characteristics of a novel mutation rtM204Q in the reverse-transcriptase domain of hepatitis B virus isolated from a chronic hepatitis B patient receiving lamivudine treatment | 2012 | 1 |
About Lanlan Si
Lanlan Si is a scholar working on Epidemiology, Nuclear Energy and Engineering, Waste Management and Disposal, Infectious Diseases and Organic Chemistry, having authored 21 papers that have together received 386 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (21 papers). The work is most often cited by research in Epidemiology (323 citations), Complementary and alternative medicine (10 citations), Pharmacology (11 citations), Hepatology (6 citations) and Genetics (16 citations). Lanlan Si has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Dongping Xu, Zhihui Xu, Rongjuan Chen, Yan Liu, Xiaodong Li, Yan Liu, Jianhong Chen, Hao Liao, Dong Ji and Shan-shan Lu. Their work appears in journals such as Antiviral Research, Journal of Clinical Virology, World Journal of Gastroenterology, Journal of Medical Virology and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.